Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing Operations Income towards Parent Company Interest Expenses Interest Expenses Net Income towards Common Stockholders Operating Expenses Operating Income Profit After Tax Restructuring Costs Revenue Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Outstanding Shares Outstanding

Ratios

Amdocs (DOX) Shares Outstanding (2016 - 2025)

Amdocs (DOX) has disclosed Shares Outstanding for 17 consecutive years, with $108.4 million as the latest value for Q3 2025.

Quarterly Shares Outstanding fell 62.41% to $108.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $108.4 million through Sep 2025, down 62.41% year-over-year, with the annual reading at $108.4 million for FY2025, 62.41% down from the prior year.
Shares Outstanding for Q3 2025 was $108.4 million at Amdocs, down from $112.9 million in the prior quarter.
The five-year high for Shares Outstanding was $124.9 million in Q3 2021, with the low at $108.4 million in Q3 2025.
Average Shares Outstanding over 5 years is $116.9 million, with a median of $117.3 million recorded in 2023.
The sharpest move saw Shares Outstanding soared 145.84% in 2024, then tumbled 62.41% in 2025.
Over 5 years, Shares Outstanding stood at $124.9 million in 2021, then dropped by 3.22% to $120.8 million in 2022, then decreased by 2.89% to $117.3 million in 2023, then soared by 145.84% to $288.5 million in 2024, then crashed by 62.41% to $108.4 million in 2025.
According to Business Quant data, Shares Outstanding over the past three periods came in at $108.4 million, $288.5 million, and $117.3 million for Q3 2025, Q3 2024, and Q3 2023 respectively.